Company Description
Prenetics Global Limited, a health sciences company, focuses on advancing consumer and clinical health.
The company’s consumer initiatives is led by IM8, a new health and wellness brand. Its prevention arm, CircleDNA, uses next-generation sequencing (NGS) technology to offer comprehensive consumer DNA test.
It also develops and commercializes multi-cancer early detection technologies. In addition, the company offers a range of genomic profiling panels tailored for requirements and clinician needs, including ACTOnco, ACT HRD, ACTFusion, and ACTDrug tests.
Further, the company offers ACTLiquid Pro, a sequencing based liquid biopsy assay for pan-solid tumors; ACTMonitor, which provides real time monitoring of drug resistance, treatment response, and cancer recurrence; and ACT Risk, which manages the cancer risk.
Additionally, it is involved in the sports distribution activities providing sports nutrition products to fitness facilities.
The company operates in Taiwan, Hong Kong, the United Kingdom, and internationally. The company was founded in 2014 and is based in Quarry Bay, Hong Kong and has a presence in the United States.
| Country | Hong Kong |
| Founded | 2014 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 324 |
| CEO | Sheng Wu Yeung |
Contact Details
Address: Unit 703-706, K11 Atelier King’s Road, 728 King’s Road Quarry Bay Hong Kong | |
| Phone | 852 2210 9588 |
| Website | prenetics.com |
Stock Details
| Ticker Symbol | PRE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001876431 |
| CUSIP Number | G72245106 |
| ISIN Number | KYG722451229 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Walt Ling | Chief Executive Officer of ACT Genomics |
| Joel Neoh | Chief Consumer Officer and Chief Executive Officer for CircleDNA |
| Samantha Kwok | Chief of Staff to Group Chief Executive Officer and Vice President of People & Operations |
| Sheng Wu Yeung | Co-Founder, Chairperson and Chief Executive Officer |
| Dr. Chi Hung Tzang Ph.D. | Co-Founder and Chief Scientific Officer |
| Hoi Chun Lo | Chief Financial Officer |
| Dr. Yung Ho Wong DPHIL | Chief Technology Officer |
| Dr. Senthil Sundaram M.D. | Chief Clinical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 13, 2024 | 6-K | Report of foreign issuer |
| Nov 27, 2024 | 6-K | Report of foreign issuer |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 7, 2024 | SCHEDULE 13G/A | Filing |
| Oct 15, 2024 | 6-K | Report of foreign issuer |
| Oct 7, 2024 | 6-K | Report of foreign issuer |
| Sep 27, 2024 | 6-K | Report of foreign issuer |
| Sep 16, 2024 | 6-K | Report of foreign issuer |
| Aug 19, 2024 | 6-K | Report of foreign issuer |
| Jul 11, 2024 | 6-K/A | Filing |